| Literature DB >> 25548432 |
Antonio Siniscalchi1, Giorgio Ercolani2, Giulia Tarozzi1, Lorenzo Gamberini1, Lucia Cipolat1, Antonio D Pinna2, Stefano Faenza1.
Abstract
Introduction. Laparoscopic liver resection is considered risky in cirrhotic patients, even if minor surgical trauma of laparoscopy could be useful to prevent deterioration of a compromised liver function. This study aimed to identify the differences in terms of perioperative complications and early outcome in cirrhotic patients undergoing minor hepatic resection for hepatocellular carcinoma with open or laparoscopic technique. Methods. In this retrospective study, 156 cirrhotic patients undergoing liver resection for hepatocellular carcinoma were divided into two groups according to type of surgical approach: laparoscopy (LS group: 23 patients) or laparotomy (LT group: 133 patients). Perioperative data, mortality, and length of hospital stay were recorded. Results. Groups were matched for type of resection, median number of nodules, and median diameter of largest lesions. Groups were also homogeneous for preoperative liver and renal function tests. Intraoperative haemoglobin decrease and transfusions of red blood cells and fresh frozen plasma were significantly lower in LS group. MELD score lasted stable after laparoscopic resection, while it increased in laparotomic group. Postoperative liver and renal failure and mortality were all lower in LS group. Conclusions. Lower morbidity and mortality, maintenance of liver function, and shorter hospital stay suggest the safety and benefit of laparoscopic approach.Entities:
Year: 2014 PMID: 25548432 PMCID: PMC4274825 DOI: 10.1155/2014/871251
Source DB: PubMed Journal: HPB Surg ISSN: 0894-8569
The two groups (laparoscopic versus open resection) were matched based on type of resection and median number and diameter of nodules.
| Variables | LS group (23) | LT group (133) | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD |
| |
|
| |||||
| Preoperative data | |||||
| Number of lesions | 1.23 (1–3) | 0.56 | 1.26 (1–6) | 0.68 | 0.898 |
| Diameter of the lesion (cm) | 3.21 (1.9–8) | 1.04 | 3.6 (1–9) | 1.64 | 0.074 |
|
| |||||
| Number | % | Number | % |
| |
|
| |||||
| Type of resection | |||||
| Wedge ( | 10 | 43.5% | 90 | 67.7% | 0.165 |
| Segmentectomy ( | 8 | 34.8% | 27 | 20.3% | |
| Bisegmentectomy ( | 2 | 8.7% | 8 | 6.0% | |
| Left lobectomy ( | 3 | 13% | 8 | 6.0% | |
Preoperative data, clinical variables, comorbidities, and complications related to cirrhosis divided according to type of resection.
| Variables | LS group (23) | LT group (133) | |||
|---|---|---|---|---|---|
| Mean | SD | Mean | SD |
| |
|
| |||||
| Age ( | 57.91 | 10.92 | 63.26 | 7.89 | 0.033* |
| Male/female | 15/8 | 104/29 | 0.19 | ||
|
| |||||
| Number | % | Number | % |
| |
|
| |||||
| Pathologies | |||||
| Alcohol ( | 5 | 21.7% | 6 | 4.5% | 0.011* |
| HCV ( | 17 | 73.9% | 88 | 67.6% | 1 |
| HBV ( | 6 | 26.1% | 35 | 26.5% | 1 |
| HDV ( | 1 | 4.3% | 5 | 3.8% | 1 |
| HIV ( | 3 | 13% | 19 | 14.4% | 1 |
| Diabetes ( | 4 | 17.4% | 36 | 27.3% | 0.441 |
| Preoperative ascites ( | 3 | 13% | 8 | 6.1% | 0.211 |
| Esophageal varices ( | 13 | 56.6% | 40 | 34.8% | 0.062 |
|
| |||||
| Mean | SD | Mean | SD |
| |
|
| |||||
| Preoperative data | |||||
| Serum urea (g/L) | 0.37 | 0.12 | 0.4 | 0.17 | 0.521 |
| Serum creatinine (mg/dL) | 0.9 | 0.2 | 0.98 | 0.29 | 0.197 |
| Proteins (g/dL) | 7.59 | 0.71 | 7.57 | 0.6 | 0.878 |
| Albumin (g/dL) | 3.91 | 0.39 | 3.73 | 0.41 | 0.139 |
| Bilirubin (mg/dL) | 1.45 | 1.18 | 0.98 | 0.51 | 0.074 |
| ALP (U/L) | 305.5 | 103.65 | 281.55 | 108.28 | 0.597 |
| AST (U/L) | 60 | 30.84 | 86.78 | 77.08 | 0.103 |
| ALT (U/L) | 55.48 | 43.38 | 87.76 | 72.41 | 0.04* |
| INR | 1.25 | 0.17 | 1.16 | 0.11 | 0.015* |
| MELD | 10.09 (7–18) | 3.04 | 8.95 | 1.82 | 0.096 |
| Na+ (mmol/L) | 140.65 | 3.5 | 138.8 | 2.67 | 0.023* |
| WBC (U/mL) | 5272.61 | 2125.79 | 5389.83 | 1728.14 | 0.772 |
| Hb (g/dL) | 13.36 | 1.74 | 13.9 | 1.47 | 0.119 |
| HCT (%) | 39.2 | 4.37 | 41.17 | 4 | 0.035* |
| PLT (U/mL) | 111 217 | 60 336 | 138 439 | 59 880 | 0.046* |
* P < 0.05.
Intraoperative respiratory and metabolic parameters, transfusions, and operative time divided in two groups according to type of surgical approach; RBC: red blood cells; FFP: fresh frozen plasma; PT RBC/FFP: patients transfused with units of RBC/FFP.
| Variables | LS group (23) | LT group (133) | |||
|---|---|---|---|---|---|
| Intraoperative data | |||||
|
| |||||
| Mean | SD | Mean | SD |
| |
|
| |||||
| Basal PaO2 (mmHg) | 253.02 | 109.88 | 227.29 | 66.57 | <0.001* |
| Worst PaO2 (mmHg) | 181.53 | 75.86 | 235.29 | 68.77 | <0.001* |
| Basal PaCO2 (mmHg) | 34.94 | 5.07 | 35.74 | 4.8 | <0.001* |
| Worst PaCO2 (mmHg) | 43.75 | 8.56 | 35.96 | 4.65 | <0.001* |
| Basal pH | 7.44 | 0.04 | 7.43 | 0.05 | <0.001* |
| Worst pH | 7.35 | 0.07 | 7.39 | 0.06 | <0.001* |
| Basal HCO3 − (mmol/L) | 23.38 | 2.46 | 24.04 | 1.73 | <0.001* |
| Worst HCO3 − (mmol/L) | 23.65 | 2.37 | 21.93 | 1.97 | <0.001* |
| Basal BE (mmol/L) | −0.49 | 2.05 | −0.61 | 2.06 | 0.595 |
| Worst BE (mmol/L) | −2.3 | 2.53 | −2.69 | 2.56 | 0.595 |
| Basal Hb (g/dL) | 11.96 | 1.62 | 12.23 | 1.58 | <0.001* |
| Worst Hb (g/dL) | 12.11 | 1.84 | 11.21 | 1.7 | <0.001* |
| RBC (U) | 0 | 0 | 0.58 | 1.1 | <0.001* |
| FFP (U) | 0.22 | 0.52 | 0.68 | 1.07 | 0.002* |
|
| |||||
| Number | % | Number | % |
| |
|
| |||||
| PT RBC | 0 | 0% | 36 | 27.4% | 0.002* |
| PT FFP | 4 | 17.4% | 45 | 34.2% | 0.143 |
| Acidosis correction (NaHCO3) | 2 | 8.7% | 16 | 19% | 0.35 |
|
| |||||
| Min | SD | Min | SD |
| |
|
| |||||
| Operative time | 175 | 91 | 165 | 80 | 0.588 |
* P < 0.05.
Pathologic tumor characteristics and curative resection based on laparoscopic versus open resection.
| Variables | LS group (23) | LT group (133) |
| ||
|---|---|---|---|---|---|
| Number | % | Number | % | ||
| Edmonds on grades I-II | 8 | 34.8% | 42 | 31.6% | 0.951 |
| Edmonds on grades III-IV | 15 | 65.2% | 91 | 68.4% | |
|
| |||||
| Microvascular invasion (yes) | 13 | 56.5 | 71 | 53.4 | 0.958 |
| Microvascular invasion (no) | 10 | 43.5 | 62 | 46.6 | |
|
| |||||
| Curative resection (R0) | 22 | 95.6% | 129 | 97.0% | 0.761 |
Postoperative data: hepatic and renal functions, coagulopathies, other morbidities, mortality, and hospital stay divided in two groups according to type of surgical approach.
| Variables | LS group (23) | LT group (133) | |||
|---|---|---|---|---|---|
| Postoperative data | |||||
|
| |||||
| Mean | SD | Mean | SD |
| |
|
| |||||
| Worse creatinine (mg/dL) | 0.84 | 0.18 | 1.18 | 0.44 | <0.001* |
| Worse bilirubin (mg/dL) | 2.48 | 1.45 | 2.17 | 3.43 | 0.673 |
| Worse INR | 1.33 | 0.18 | 1.33 | 0.19 | 0.987 |
| Worse MELD | 10.6 | 3.58 | 12.6 | 4.24 | 0.035* |
|
| |||||
| Number | % | Number | % |
| |
|
| |||||
| PO ascites | 3 | 13% | 34 | 25.8% | 0.288 |
| PO jaundice | 10 | 43.5% | 30 | 22.7% | 0.067 |
| 50-50 criterion | 8 | 34.8% | 17 | 12.9% | 0.014* |
| PO coagulopathy | 5 | 21.7% | 25 | 18.9% | 0.777 |
| PO renal failure | 0 | 0% | 9 | 6.8% | 0.357 |
| POLF | 0 | 0% | 9 | 6.8% | 0.357 |
| Treatment of POLF | 0 | 0% | 3 | 2.3% | 0.475 |
| Morbidity | 5 | 21.7% | 47 | 35.6% | 0.237 |
| Status (dead/alive) | 0/23 | 0/100% | 10/123 | 7.5/92.5% | 0.36 |
|
| |||||
| Mean | SD | Mean | SD |
| |
|
| |||||
| Hospital stay ( | 7.61 (3–29) | 5.5 | 14.38 (4–166) | 21.78 | 0.339 |
* P < 0.05.